Pulmonary embolism and Cognitive disorder

Summary:

Cognitive disorder is found among people with Pulmonary embolism, especially for people who are male, 60+ old.

The study analyzes which people have Cognitive disorder with Pulmonary embolism. It is created by eHealthMe based on reports of 38 people who have Pulmonary embolism from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Pulmonary embolism?

Pulmonary embolism (blockage of the main artery of the lung) is found to be associated with 2,333 drugs and 2,956 conditions by eHealthMe. Check the latest studies of Pulmonary embolism.

What is Cognitive disorder?

Cognitive disorder (mental health disorders affects learning, memory, perception, and problem solving) is found to be associated with 1,657 drugs and 1,727 conditions by eHealthMe. Check the latest studies of Cognitive disorder.



On Jul, 12, 2026

38 people who have Pulmonary Embolism and Cognitive Disorder are studied.

Would you have Cognitive disorder when you have Pulmonary embolism?

Gender of people who have Pulmonary Embolism and experienced Cognitive Disorder *:

  • female: 50 %
  • male: 50 %

Age of people who have Pulmonary Embolism and experienced Cognitive Disorder *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 5.71 %
  • 20-29: 5.71 %
  • 30-39: 5.71 %
  • 40-49: 5.71 %
  • 50-59: 2.86 %
  • 60+: 74.29 %

Common co-existing conditions for these people *:

  1. Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 9 people, 23.68%
  2. Embolism Venous (embolus may pass into the arterial system): 7 people, 18.42%
  3. Pain: 4 people, 10.53%
  4. Multiple Myeloma (cancer of the plasma cells): 4 people, 10.53%
  5. Attention Deficit Hyperactivity Disorder (a chronic condition including attention difficulty, hyperactivity, and impulsiveness): 3 people, 7.89%
  6. Diarrhea: 3 people, 7.89%
  7. Constipation: 2 people, 5.26%
  8. Endometrial Cancer: 2 people, 5.26%
  9. Lung Adenocarcinoma (a form of non-small cell lung cancer): 2 people, 5.26%
  10. Lung Neoplasm Malignant (cancer tumour of lung): 2 people, 5.26%

Common drugs taken by these people *:

  1. Xarelto: 12 people, 31.58%
  2. Coumadin: 9 people, 23.68%
  3. Eliquis: 8 people, 21.05%
  4. Zometa: 4 people, 10.53%
  5. Prednisone: 4 people, 10.53%
  6. Rivaroxaban: 4 people, 10.53%
  7. Revlimid: 4 people, 10.53%
  8. Xgeva: 3 people, 7.89%
  9. Trintellix: 3 people, 7.89%
  10. Xanax: 3 people, 7.89%

Common symptoms for these people *:

  1. Weakness: 10 people, 26.32%
  2. Fatigue (feeling of tiredness): 10 people, 26.32%
  3. Pain: 7 people, 18.42%
  4. Headache (pain in head): 6 people, 15.79%
  5. Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 6 people, 15.79%
  6. Dyspnea (difficult or laboured breathing): 5 people, 13.16%
  7. Stress And Anxiety: 4 people, 10.53%
  8. Thrombosis (formation of a blood clot inside a blood vessel): 4 people, 10.53%
  9. Drug Ineffective: 4 people, 10.53%
  10. Swallowing Difficulty: 4 people, 10.53%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Cognitive disorder?

- Check whether Cognitive disorder is associated with a drug or a condition


Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Cognitive disorder:

All the conditions that are associated with Cognitive disorder:


How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Cognitive disorder and Pulmonary embolism, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: